C07D 413/14
Containing three or more hetero rings
Official title: containing three or more hetero rings
C07D413/14 (Containing three or more hetero rings) appears on 8,515 US grants and 11,657 published applications in this corpus.
Search patents in C07D- Granted patents
- 8,515
- Published applications
- 11,657
- Assignees
- 2,593
- Inventors
- 25,120
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 2 | 0 |
| 1978 | 10 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 3 | 0 |
| 1983 | 3 | 0 |
| 1984 | 3 | 0 |
| 1985 | 7 | 0 |
| 1986 | 7 | 0 |
| 1987 | 15 | 0 |
| 1988 | 16 | 0 |
| 1989 | 28 | 0 |
| 1990 | 22 | 0 |
| 1991 | 27 | 0 |
| 1992 | 37 | 0 |
| 1993 | 42 | 0 |
| 1994 | 35 | 0 |
| 1995 | 42 | 0 |
| 1996 | 75 | 0 |
| 1997 | 82 | 0 |
| 1998 | 68 | 0 |
| 1999 | 81 | 0 |
| 2000 | 85 | 0 |
| 2001 | 83 | 11 |
| 2002 | 111 | 104 |
| 2003 | 128 | 194 |
| 2004 | 76 | 310 |
| 2005 | 92 | 321 |
| 2006 | 152 | 285 |
| 2007 | 187 | 369 |
| 2008 | 172 | 358 |
| 2009 | 213 | 476 |
| 2010 | 276 | 535 |
| 2011 | 271 | 490 |
| 2012 | 396 | 491 |
| 2013 | 459 | 570 |
| 2014 | 531 | 568 |
| 2015 | 497 | 568 |
| 2016 | 424 | 518 |
| 2017 | 470 | 501 |
| 2018 | 399 | 503 |
| 2019 | 458 | 567 |
| 2020 | 432 | 569 |
| 2021 | 380 | 508 |
| 2022 | 355 | 540 |
| 2023 | 291 | 705 |
| 2024 | 302 | 643 |
| 2025 | 395 | 557 |
| 2026 | 269 | 396 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- PHD inhibitor compounds, compositions, and use6 Oct 2026US 12,753,161 B2Akebia Therapeutics, Inc.
- Diaminopyrimidine carboxamide inhibitors of HPK16 Oct 2026US 12,753,163 B2Merck Sharp & Dohme Corp.
- Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof6 Oct 2026US 12,753,170 B2Akagera Medicines, Inc.
- Derivatives of substituted morpholines and uses thereof29 Sep 2026US 12,747,218 B2Supernus Pharmaceuticals, Inc.
- EAAT2 activators and methods of using thereof29 Sep 2026US 12,747,227 B2Ohio State Innovation Foundation
- Antidegradant bis(dihydro and tetrahydroquinoline) compounds and uses thereof8 Oct 2026US 2026/0308127 A1Flexsys IP Holdings, LLC
- Triazolyl-containing compounds8 Oct 2026US 2026/0308146 A1Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Substituted oxoisoindolinyl piperidine-2,6-dione compounds and aza analogs thereof8 Oct 2026US 2026/0308147 A1
- Anthelmintic aza-benzothiophene and aza-benzofuran compounds8 Oct 2026US 2026/0308170 A1Boehringer Ingelheim Vetmedica GmbH
- Organic electroluminescent compound, a plurality of host materials, and organic electroluminescent device comprising the same8 Oct 2026US 2026/0314256 A1
Most cited
By later US patents
- Sulfamoylheleroaryl pyrazole compounds as anti-inflammatory/analgesic agents332US 6,603,008 B1Pfizer Inc. · 2003
- Substituted biphenyl isoxazole sulfonamides222US 5,612,359 ABristol-Myers Squibb Company · 1997
- Intermediates useful for making 2,4-pyrimidinediamine compounds192US 7,060,827 B2Rigel Pharmaceuticals, Inc. · 2006
- Quinoline derivatives as PI3 kinase inhibitors178US 8,138,347 B2GlaxoSmithKline LLC · 2012
- 2,4-disubstituted pyrimidines useful as kinase inhibitors178US 8,338,439 B2Celgene Avilomics Research, Inc. · 2012